Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Champions Oncology (CSBR) Return on Assets (2016 - 2026)

Champions Oncology has reported Return on Assets over the past 16 years, most recently at 0.08% for Q1 2026.

  • Quarterly results put Return on Assets at 0.08% for Q1 2026, down 31.0% from a year ago — trailing twelve months through Jan 2026 was 0.08% (down 31.0% YoY), and the annual figure for FY2025 was 0.16%, up 40.0%.
  • Return on Assets for Q1 2026 was 0.08% at Champions Oncology, down from 0.08% in the prior quarter.
  • Over the last five years, Return on Assets for CSBR hit a ceiling of 0.23% in Q1 2025 and a floor of 0.35% in Q1 2024.
  • Median Return on Assets over the past 5 years was 0.02% (2024), compared with a mean of 0.06%.
  • Biggest five-year swings in Return on Assets: tumbled -33bps in 2023 and later surged 58bps in 2025.
  • Champions Oncology's Return on Assets stood at 0.0% in 2022, then crashed by -10948bps to 0.33% in 2023, then soared by 93bps to 0.02% in 2024, then skyrocketed by 436bps to 0.08% in 2025, then plummeted by -200bps to 0.08% in 2026.
  • The last three reported values for Return on Assets were 0.08% (Q1 2026), 0.08% (Q4 2025), and 0.09% (Q3 2025) per Business Quant data.